P. Rutgeerts

Genetics · 2002–2019

A researcher in the Science corpus: 36 papers; trusts 1 researcher and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom P. Rutgeerts trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. W. Sandborn

Who trusts P. Rutgeerts overall

  1. W. Sandborn
  2. Markus F. Neurath
  3. Stefan Schreiber
  4. S. Ben-Horin
  5. B. Feagan
  6. G. Lichtenstein

Papers from P. Rutgeerts's perspective

Ordered by how strongly the researchers P. Rutgeerts trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. (Gastroenterology)
  2. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. (Gastroenterology)
  3. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. (Gastroenterology)
  4. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee (American Journal of Gastroenterology)
  5. Inflammatory bowel disease: clinical aspects and established and evolving therapies (The Lancet)
  6. Infliximab maintenance therapy for fistulizing Crohn's disease. (New England Journal of Medicine)
  7. A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene (Science)
  8. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 (Nature Genetics)
  9. The immunological and genetic basis of inflammatory bowel disease (Nature reviews. Immunology)
  10. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease (Nature)

Their papers